New drug combination may improve treatment for rare nerve sheath tumors
Combining a pair of experimental drugs may help treat malignant peripheral nerve sheath tumors with fewer harmful side effects, according to preliminary animal studies led by investigators at the Johns...
View ArticleDoes tinnitus cause hearing loss in normal hearing individuals?
Whether cochlear neural degeneration occurs in normal-hearing individuals with tinnitus.
View ArticleCombination drug treatment could be effective against malignant peripheral...
A combination of two cancer drugs could be effective against malignant peripheral nerve sheath tumors (MPNSTs) -; soft tissue tumors that are stubbornly resistant to chemotherapy and radiation -;...
View ArticleResearchers identify increased brain tumor risk with specific contraceptive use
The intracranial meningioma risk associated with progestogen use.
View ArticleCertain progestogens linked to higher brain tumor risk in women, study suggests
Study finds long-term use of specific progestogens increases the risk of benign brain tumors in women, while short-term use and other progestogens do not.
View ArticleVosoritide's first phase 2 study shows increased growth in children with...
Vosoritide's first global phase 2 study showed an average increased growth rate of 1.8 cm per year in children with hypochondroplasia, a genetic cause of short stature in children, according to...
View ArticleEpilepsy drug prevents brain tumor formation and growth in mouse models of NF1
A drug used to treat children with epilepsy prevents brain tumor formation and growth in two mouse models of neurofibromatosis type 1 (NF1), according to a study by researchers at Washington University...
View ArticleRepurposing anti-retroviral medications for brain tumor treatment: The...
Drugs developed to combat HIV and AIDS are being trialed for the first time in patients with multiple brain tumors.
View ArticleNew treatment identified for peripheral nerve sheath tumors
A multicenter collaboration led by the Bellvitge Biomedical Research Institute (IDIBELL) - Institut Català d'Oncologia (ICO) and the Germans Trias i Pujol Research Institute (IGTP) identified a...
View ArticleResearchers challenge previous understanding of tumor growth in NF-1
Despite what was previously thought, new research has shown that genetic changes alone cannot explain why and where tumors grow in those with genetic condition neurofibromatosis type 1 (NF-1).
View Article